Sustained good response to rituximab in acquired von Willebrand syndrome

被引：0
|
作者：
Mistry, Jayna [1 ]
Lowe, Gillian Clare [1 ]
Lester, Will [1 ]
Percy, Charles Llewellyn [1 ]
机构：
[1] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, West Midlands Adult Comprehens Care Haemophilia &, Birmingham B15 2TH, England
来源：
BLOOD COAGULATION & FIBRINOLYSIS | 2024年 / 35卷 / 03期
关键词：
D O I：
10.1097/MBC.0000000000001278
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：147 / 149
页数：3
相关论文
共 50 条
  • [41] Diagnosis and treatment of acquired von Willebrand syndrome
    Tiede, Andreas
    THROMBOSIS RESEARCH, 2012, 130 : S2 - S6
  • [42] Acquired von Willebrand syndrome in aortic stenosis
    Vincentelli, A
    Susen, S
    Le Tourneau, T
    Six, I
    Fabre, O
    Juthier, F
    Bauters, A
    Decoene, C
    Goudemand, J
    Prat, A
    Jude, B
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (04): : 343 - 349
  • [43] Diagnostic Challenges in Acquired von Willebrand Syndrome: A Complex Case of Prostate Carcinoma Associated-Acquired von Willebrand Syndrome
    Claus, Paul-Emile
    Van Haute, Inge
    Verhoye, Eline
    Deeren, Dries
    Moreau, Els
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2017, 43 (01): : 101 - 104
  • [44] Response to DDAVP in acquired von Willebrand syndrome due to IgM monoclonal gammopathy
    Staritz, P.
    Lages, P.
    Zimmermann, R.
    Huth-Kuehne, A.
    HAMOSTASEOLOGIE, 2010, 30 (4A): : S177 - S178
  • [45] Treatment of acquired von Willebrand syndrome with von Willebrand factor-containing concentrate
    Tiede, A.
    Priesack, J. .
    Werwitzke, S.
    Trummer, A.
    Ganser, A.
    Budde, U.
    HAEMOPHILIA, 2008, 14 : 1 - 2
  • [46] A candidate mechanism for von Willebrand factor abnormalities in a patient with acquired von Willebrand syndrome
    Haj, MA
    Murch, N
    Bowen, DJ
    Collin, PW
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 43 - 43
  • [47] Successful treatment of acquired von Willebrand syndrome secondary to low-grade CLL with rituximab and venetoclax
    Boothby, Aaron
    Hegerova, Livia
    Fletcher, Shelley N.
    Shadman, Mazyar
    Johnsen, Jill M.
    LEUKEMIA & LYMPHOMA, 2024, 65 (13) : 2068 - 2070
  • [48] Rituximab failure in a patient with monoclonal gammopathy of undetermined significance (MGUS)-associated acquired von Willebrand syndrome
    Grimaldi, David
    Bartolucci, Pablo
    Gouault-Heilmann, Michele
    Martin-Toutain, Isabelle
    Khellaf, Mehdi
    Godeau, Bertrand
    THROMBOSIS AND HAEMOSTASIS, 2008, 99 (04) : 782 - 783
  • [49] Rituximab to the rescue: novel therapy for chronic gastrointestinal bleeding due to angiodysplasia and acquired von Willebrand syndrome
    Hawken, James
    Knott, Amy
    Alsakkaf, Wesam
    Clark, Amanda
    Fayyaz, Faisal
    FRONTLINE GASTROENTEROLOGY, 2019, 10 (04) : 434 - 437
  • [50] Maintaining hemostasis in acquired von Willebrand syndrome: a review of intravenous immunoglobulin and the importance of rituximab dose scheduling
    Kanakry, Jennifer A.
    Gladstone, Douglas E.
    TRANSFUSION, 2013, 53 (08) : 1730 - 1735
12345